News
Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...
12h
Zacks.com on MSNHere's What to Expect From Pfizer's Non-Oncology Drugs in Q2 EarningsPFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.
Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially ...
12h
24/7 Wall St. on MSNThe 5%+ Dividend Stocks I Love TodayLee, at this point in the year, all the companies that pay dividends have pretty much set their dividends. You know, the ...
Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...
It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...
Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...
NASCAR will hold a street race on Naval Base Coronado in Southern California next June as a replacement for its downtown ...
Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...
Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...
Viatris (VTRS) stock dips after its experimental therapy for eyelid inflammation fails a Phase 3 trial. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results